The prognostic value of the MAGGIC risk score in patients with acute pulmonary embolism

MakaleYalnız künyeScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Objectives: Acute pulmonary embolism (PE) is a potentially life-threatening condition characterized by the sudden blockage of the pulmonary arteries. Although the MAGGIC risk score has emerged as a valuable tool in predicting outcomes in patients with chronic heart failure, it has also been demonstrated and identified as a prognostic model in various cardiac diseases other than heart failure. In this study, we aimed to investigate the relationship between MAGGIC score and adverse outcomes in patients with PE. Materials and Methods: A total of 302 consecutive patients diagnosed with acute PE were retrospectively included in the present study. For each patient, the MAGGIC score was calculated. The study population was divided into two groups according to the median value of MAGGIC score. Results: Patients with high MAGGIC score had a significantly higher proportion of elderly and female individuals, lower BMI, higher presence of CAD, DM, AFib, HF, HT, CKD, COPD, and ACEI/ARB and NOAC usage. Logistic regression analyses was carried out using univariate and multivariate analysis to predict the in-hospital and 30-day mortality predictors in the included PE patients. For in-hospital mortality, diastolic blood pressure, heart rate, RV dilatation, and the MAGGIC score (HR: 1.166, 95% CI 1.077–1.263, p < 0.001) and for short-term mortality, sPESI and the MAGGIC score (HR: 1.925, 95% CI 1.243–2.983, p:0.003) were found to be independent predictors for adverse outcomes in patients with acute PE. Conclusion: Our study demonstrates that the MAGGIC score can be applied as a valuable prognostic tool for acute pulmonary embolism.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/kostu/10570Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1016/j.amjms.2024.07.029Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
6
WoS
4
OpenAlex
6
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorArtac, Inanc
dc.contributor.authorIlis, Dogan
dc.contributor.authorKarakayali, Muammer
dc.contributor.authorOmar, Timor
dc.contributor.authorArslan, Ayca
dc.contributor.authorTopaloğlu, Ihsan
dc.contributor.authorKarabag, Yavuz
dc.contributor.authorKarakayon, Suleyman
dc.contributor.authorRencuzogullari, Ibrahim
dc.date.accessioned2026-10-27T23:47:38.901974008Z
dc.date.available2026-10-27T23:47:38.901974008Z
dc.date.issued2025
dc.description.abstractObjectives: Acute pulmonary embolism (PE) is a potentially life-threatening condition characterized by the sudden blockage of the pulmonary arteries. Although the MAGGIC risk score has emerged as a valuable tool in predicting outcomes in patients with chronic heart failure, it has also been demonstrated and identified as a prognostic model in various cardiac diseases other than heart failure. In this study, we aimed to investigate the relationship between MAGGIC score and adverse outcomes in patients with PE. Materials and Methods: A total of 302 consecutive patients diagnosed with acute PE were retrospectively included in the present study. For each patient, the MAGGIC score was calculated. The study population was divided into two groups according to the median value of MAGGIC score. Results: Patients with high MAGGIC score had a significantly higher proportion of elderly and female individuals, lower BMI, higher presence of CAD, DM, AFib, HF, HT, CKD, COPD, and ACEI/ARB and NOAC usage. Logistic regression analyses was carried out using univariate and multivariate analysis to predict the in-hospital and 30-day mortality predictors in the included PE patients. For in-hospital mortality, diastolic blood pressure, heart rate, RV dilatation, and the MAGGIC score (HR: 1.166, 95% CI 1.077–1.263, p < 0.001) and for short-term mortality, sPESI and the MAGGIC score (HR: 1.925, 95% CI 1.243–2.983, p:0.003) were found to be independent predictors for adverse outcomes in patients with acute PE. Conclusion: Our study demonstrates that the MAGGIC score can be applied as a valuable prognostic tool for acute pulmonary embolism.
dc.identifier.doi10.1016/j.amjms.2024.07.029
dc.identifier.eissn1538-2990
dc.identifier.endpage87
dc.identifier.issn0002-9629
dc.identifier.issue1
dc.identifier.pmid39094978
dc.identifier.scopus2-s2.0-85201631509
dc.identifier.startpage77
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/kostu/10570
dc.identifier.volume369
dc.identifier.wosWOS:001412256800001
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofAmerican Journal of the Medical Sciences
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAcute Pulmonary Embolism
dc.subjectIn-hospital
dc.subjectMAGGIC score
dc.subjectMortality
dc.subjectShort-term
dc.subject.classificationMedicine, General & Internal
dc.subject.classificationGeneral & Internal Medicine
dc.subject.otherAcute Disease
dc.subject.otherAged
dc.subject.otherAged, 80 and over
dc.subject.otherFemale
dc.subject.otherHospital Mortality
dc.subject.otherHumans
dc.subject.otherMale
dc.subject.otherMiddle Aged
dc.subject.otherPrognosis
dc.subject.otherPulmonary Embolism
dc.subject.otherRetrospective Studies
dc.subject.otherRisk Assessment
dc.subject.otherRisk Factors
dc.subject.otherbeta adrenergic receptor blocking agent
dc.subject.otherchemicals and drugs
dc.subject.otherdihydropyridine derivative
dc.subject.otherdipeptidyl carboxypeptidase inhibitor
dc.subject.otherhydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subject.othernondihydropyridine
dc.subject.otherunclassified drug
dc.subject.otherwarfarin
dc.subject.otherArticle
dc.subject.otherblood pressure
dc.subject.otherbody mass
dc.subject.otherclinical outcome
dc.subject.othercomputer assisted tomography
dc.subject.otherdiastolic blood pressure
dc.subject.otherfollow up
dc.subject.otherheart failure
dc.subject.otherheart left ventricle ejection fraction
dc.subject.otherheart rate
dc.subject.otherhospitalization
dc.subject.otherhuman
dc.subject.otherin-hospital mortality
dc.subject.otherleft ventricular end-diastolic diameter
dc.subject.otherlung embolism
dc.subject.othermaggic risk score
dc.subject.othermajor clinical study
dc.subject.othermortality
dc.subject.otheroxygen saturation
dc.subject.otherprognostic assessment
dc.subject.otherPulmonary Embolism Severity Index
dc.subject.otherretrospective study
dc.subject.otherscoring system
dc.subject.othershort term mortality
dc.subject.otherdiagnosis
dc.subject.otherprocedures
dc.subject.otherrisk factor
dc.subject.othervery elderly
dc.titleThe prognostic value of the MAGGIC risk score in patients with acute pulmonary embolism
dc.typeArticle
rdl.citation.openalex6
rdl.citation.scopus6
rdl.citation.wos4
rdl.departmentKafkas University Faculty of Medicine Department of Cardiology Kars Turkey
rdl.departmentKafkas University Faculty of Medicine Department of Pulmonary Medicine Kars Turkey
rdl.departmentKocaeli Health and Technology University Department of Health Science Kocaeli Turkey
rdl.oa.statusclosed
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)